JSPR Overview
Upcoming Projects (JSPR)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (JSPR)
-
Diving into the topline results from the Phase 1b/2a SPOTLIGHT clinical trial of Briquilimab in patients with chronic inducible urticaria.
Ticker: JSPR
Executed On: Dec 05, 2024 at 05:00 PM EST -
Discussing the 52 week results of the Barzolvolimab Phase 2 study in CSU (Chronic Spontaneous Urticaria) at EADV 2024
Tickers: CLDX, JSPR, REGN, NVS
Executed On: Oct 09, 2024 at 12:00 PM EDT -
Discussing C-Kit targeting for CSU (chronic spontaneous urticaria), PN (prurigo nodularis, EOE (eosinophilic esophagitis), aSM (advanced systemic mastocytosis), and iSM (indolent systemic mastocytosis)
Tickers: CLDX, JSPR, BPMC, COGT
Executed On: Sep 12, 2023 at 10:30 AM EDT
Upcoming & Overdue Catalysts (JSPR)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (JSPR)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
